Abstract: In a method for separating argon by cryogenic distillation, in which a flow containing argon, oxygen and nitrogen and being more rich in argon than the air is sent to a distillation column, and an argon-rich gas flow is withdrawn at the top of the column, a portion of the argon-rich gas flow is mixed with beads to form a gas mixture containing beads, the beads being capable of adsorbing oxygen in the presence of argon at the column operating temperatures; the portion of the argon-rich gas flow mixed with the beads is condensed and then sent to the top of the column; and a bottom liquid containing beads is withdrawn from the column and treated to remove the beads, the beads removed being regenerated to remove the adsorbed oxygen and being again mixed with the argon-rich gas flow.

Abstract: A direct heat exchange and material transfer apparatus having a plurality of columns, a single stack of at least two solid metal plates of rectangular section, the plates being substantially all of the same shape and dimensions and parallel to a determined direction, each plate being separated from the adjacent plate, at least in a first direct heat exchange and material transfer zone of the apparatus, by a group of hollow metal columns that are aligned and have a section which is polygonal and has at least two parallel surfaces, the channels being parallel to the determined direction and contiguous with one another, the columns of each group each being in contact with the two metal plates on either side of the group, at least some of the columns of a group containing a material and heat exchange means.

Abstract: A unit for producing argon by cryogenic distillation, suitable for connection to a double air separation column consisting of first and second columns interconnected thermally, comprises an argon separation column surmounted with a top condenser and a denitrogenation column, means for withdrawing an argon-rich and nitrogen-depleted product (LAR) at the bottom of the denitrogenation column, means for connecting the top of the argon separation column to the denitrogenation column, means for sending a top gas from the argon separation column to the atmosphere, means for withdrawing a nitrogen-rich fluid from the top of the denitrogenation column, an analyser for measuring the nitrogen content at the top of the argon separation column, and means for opening and closing the means for connecting the top of the argon separation column to the denitrogenation column depending on the nitrogen content detected by the analyser.

Abstract: In a method for separating argon by cryogenic distillation, in which a flow containing argon, oxygen and nitrogen and being more rich in argon than the air is sent to a distillation column, and an argon-rich gas flow is withdrawn at the top of the column, a portion of the argon-rich gas flow is mixed with beads to form a gas mixture containing beads, the beads being capable of adsorbing oxygen in the presence of argon at the column operating temperatures; the portion of the argon-rich gas flow mixed with the beads is condensed and then sent to the top of the column; and a bottom liquid containing beads is withdrawn from the column and treated to remove the beads, the beads removed being regenerated to remove the adsorbed oxygen and being again mixed with the argon-rich gas flow.

Abstract: Stabilized lipid construct comprising a liposome or polymerized vesicle, a targeting entity, a therapeutic entity, and a stabilizing entity are provided, as well as methods for their preparation and use.

Abstract: Polymerized liposome particles which are linked to a targeting agent and may also be linked to a contrast enhancement agent and/or linked to or encapsulating a treatment agent. The targeting imaging enhancement polymerized liposome particles interact with biological targets holding the image enhancement agent to specific sites providing in vitro and in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology. Targeting polymerized liposomes may be linked to or encapsulate a treatment agent, such as, proteins, drugs or hormones for directed delivery to specific biological sites for treatment.

Abstract: Stabilized lipid construct comprising a liposome or polymerized vesicle, a targeting entity, a therapeutic entity, and a stabilizing entity are provided, as well as methods for their preparation and use.

Abstract: Targeted macromolecules comprising a linking carrier and more than one targeting entity are provided, as well as methods for their preparation and use.

Abstract: Targeted therapeutic agents, comprising a linking carrier, a therapeutic entity associated with the linking carrier, and at least one targeting entity are provided, as well as methods for their preparation and use.

Abstract: Polymerized liposome particles which are linked to a targeting agent and may also be linked to a contrast enhancement agent and/or linked to or encapsulating a treatment agent. The targeting imaging enhancement polymerized liposome particles interact with biological targets holding the image enhancement agent to specific sites providing in vitro and in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology. Targeting polymerized liposomes may be linked to or encapsulate a treatment agent, such as, proteins, drugs or hormones for directed delivery to specific biological sites for treatment.

Abstract: Stabilized lipid construct comprising a liposome or polymerized vesicle, a targeting entity, a therapeutic entity, and a stabilizing entity are provided, as well as methods for their preparation and use.

Abstract: In vivo imaging of disease associated tissues, including tumors and other malignant growths, infection and inflammation, is used in the discovery, screening and development of therapeutic and/or diagnostic molecular targets for intervention in the treatment of the diseases involved. In vivo imaging is used to detect spatial and temporal variations in the imaging features of disease associated tissues. The physical regions of the tissue that correlate with imaging features are then assessed for patterns of gene expression. The corresponding genes or gene products that are upregulated in the regions of interest are useful as therapeutic and imaging targets, with enhanced spatial and/or temporal specificity.

Abstract: Therapeutic and imaging agents which are comprised of a targeting entity, a therapeutic or treatment entity and a linking carrier are provided. The linking carrier imparts additional advantages to the therapeutic agents, which are not provided by conventional linking methods. Preferred agents of the present invention comprise a lipid construct, vesicle, liposome, or polymerized liposome. In some cases, the therapeutic or treatment entity is a radioisotope, chemotherapeutic agent, prodrug, toxin, or gene encoding a protein that exhibits cell toxicity. Preferably, the agent is further comprised of a stabilizing entity that imparts additional advantages to the therapeutic or imaging agent.

Abstract: Polymerized liposome particles which are linked to a targeting agent and may also be linked to a contrast enhancement agent and/or linked to or encapsulating a treatment agent. The targeting imaging enhancement polymerized liposome particles interact with biological targets holding the image enhancement agent to specific sites providing in vitro and in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology. Targeting polymerized liposomes may be linked to or encapsulate a treatment agent, such as, proteins, drugs or hormones for directed delivery to specific biological sites for treatment.

Abstract: Polymerized liposome particles which are linked to a targeting agent and may also be linked to a contrast enhancement agent and/or linked to or encapsulating a treatment agent. The targeting imaging enhancement polymerized liposome particles interact with biological targets holding the image enhancement agent to specific sites providing in vitro and in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology. Targeting polymerized liposomes may be linked to or encapsulate a treatment agent, such as, proteins, drugs or hormones for directed delivery to specific biological sites for treatment.

Abstract: Polymerized liposome particles which are linked to a targeting agent and may also be linked to a contrast enhancement agent and/or linked to or encapsulating a treatment agent. The targeting imaging enhancement polymerized liposome particles interact with biological targets holding the image enhancement agent to specific sites providing in vitro and in vivo study by magnetic resonance, radioactive, x-ray or optical imaging of the expression of molecules in cells and tissues during disease and pathology. Targeting polymerized liposomes may be linked to or encapsulate a treatment agent, such as, proteins, drugs or hormones for directed delivery to specific biological sites for treatment.